1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade
Haese, A ; Vaisanen, V ; Lilja, Hans LU
; Kattan, M W
; Rittenhouse, H G
; Pettersson, K
; Chan, D W
; Huland, H
; Sokoll, L J
and Partin, A W
(2005)
In Journal of Urology
173(3).
p.752-756
- Contribution to journal › Article
- 2004
-
Mark
Development of sensitive immunoassays for free and total human glandular kallikrein 2
Vaisanen, V ; Eriksson, S ; Ivaska, KK ; Lilja, Hans LU
; Nurmi, M
and Pettersson, K
(2004)
In Clinical Chemistry
50(9).
p.1607-1617
- Contribution to journal › Article
- 2000
-
Mark
Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA
Nurmikko, P. ; Vaisanen, V. ; Piironen, T. ; Lindgren, S. and Lilja, H. LU
(2000)
In Clinical Chemistry
46(10).
p.1610-1618
- Contribution to journal › Article
-
Mark
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
Bjartell, Anders LU ; Paju, A ; Stenman, U H ; Vaisanen, V ; Aumuller, G ; Diamandis, E ; Becker, Charlotte LU and Lilja, Hans LU
(2000)
In Prostate Cancer and Prostatic Diseases
3(Suppl 1).
p.7-7
- Contribution to journal › Article
- 1999
-
Mark
Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells
Väisänen, V. ; Lövgren, J. ; Hellman, J. ; Piironen, T. and Lilja, H. LU
(1999)
In Prostate Cancer and Prostatic Diseases
2.
p.91-97
- Contribution to journal › Article